From: Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
t-IV Bu/Flu
Bu/Cy
100 days
3%
16%
6 months
7%
18%
1 year
15%
25%
